Denovicon’s mission is to bring better quality drugs to market faster and more affordably than existing methods. To do so, we’ve created a drug discovery platform that’s powered by AI, machine learning, generative therapeutic design, and physics-based approaches to achieve the best results. The platform effectively and swiftly triages billions upon billions of (~10²⁷) molecules to identify high-quality leads (not simply hits) and transform them into optimized clinical candidates. In this way, the platform streamlines the overall drug discovery process leading to savings in time and money, while achieving higher rates of clinical success – and down the line, to better patient outcomes.